Loading
Lifeward Ltd. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Turk Joseph E Jr, was filed 17 Dec 2024.
Lifeward Ltd.: what insiders have been doing
Every trade that managers of Lifeward Ltd. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 23 October 2026, 9 filings were filed, from 9 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of Lifeward Ltd. stock was filed. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade.
Across the 3,167 companies tracked on its exchange, the median is 24 filings; at 9 filings, this issuer sits below that mark. Our records for Lifeward Ltd. go back to 2016, with 90 purchases and 96 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 22.0 m USD and net income at -19.9 m USD.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
371
Thresholds
n/a
Buy Volume
€6M
90 ops. · all time
Sell Volume
€6M
96 ops. · all time
Who traded when
BuySaleLind Global Fund II LP4 sales
Michael Swinford3 buys
Jeannine Lynch1 sale
Joseph E. Turk Jr.1 buy
Lawrence J. Jasinski1 sale
Randel Richner1 sale
Since the insiders bought
- -54.7%Entry US$18.00 · Close at T+365 US$8.16
- -71.9%Entry US$24.84 · Close at T+365 US$6.98
- -71.8%Entry US$54.00 · Close at T+365 US$15.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 25,649 of 26,248 companies
10.5
score / 100
Value1
Quality20
FCF yld-106%
Earn yld-125%
EV/EBITDA·
ROE-226%
Gross mgn38%
Net mgn-90%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$5.61
Analyst consensus
2 analysts1.50/5
US$10.00Target US$20.00(+257%)US$30.00
Income statement
RevenueUS$22M
Gross profitUS$8.4M38% margin
EBITDA-US$16.6M-75% margin
Net income-US$19.9M-141.3% margin
Valuation
PER (forward)-6.5x
P/Book1.3x
Beta0.48
Balance sheet & cash
Market capUS$15.9M
Total debtUS$4.4M
Free Cash Flow-US$16.8M
Debt / Equity57%
Profitability & ownership
ROE-225.6%
ROA-47.3%
% insiders47.1%
% institutions1.4%
Last declaration on 10 September 2026
Declarations371 total
6,711 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-004483:0
6,711 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-004304:0
13,643 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-004241:0
11,485 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-002097:0
11,485 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-002101:0
7,657 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-001816:0
7,657 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-001814:0
7,657 shares0Ordinary Shares, no par value per shareSEC:0001178913-26-001812:0
50,000 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001178913-25-004050:0
1,591 shares@ US$0.64100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-015335:0
35,920 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013872:0
35,920 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013871:0
71,839 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013870:0
35,920 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013869:0
35,920 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013868:0
35,920 shares0Ordinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-013867:0
1,909 shares@ US$1.2621.3% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-25-010097:0
298,350 shares@ US$3.4611.4% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0000929638-25-000105:1
190,734 shares@ US$1.944.1% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0000929638-25-000105:2
700 shares@ US$2.690.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0000929638-25-000105:3
83,326 shares@ US$3.01100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0000929638-25-000105:0
6,000 shares@ US$1.69100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-24-020707:0
Canonical exit: 13 Mar 2025 (T+90)
4,285 shares@ US$1.6836100.0% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001062993-24-020755:0
21,622 shares@ US$2.028441.9% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001178913-24-003854:0
Canonical exit: 23 Feb 2025 (T+90)
16,907 shares@ US$1.827629.6% of flowOrdinary Shares, par value NIS 1.75 per shareSEC:0001178913-24-003839:0
Canonical exit: 20 Feb 2025 (T+90)
25 of 371 declarations
About Lifeward Ltd.
Lifeward Ltd. is a company listed on the XNAS market, specializing in the development of innovative solutions for the healthcare sector. It focuses on enhancing patient quality of life through advanced technologies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
